Today, EMCDDA Director Alexis Goosdeel is in Brussels for an exchange of views with the European Parliament’s Committee for Environment, Public Health and Food Safety (ENVI). This, the first EMCDDA presentation before the committee, represents an important opportunity for the agency to inform ENVI members about ongoing drug-related challenges for the European Union in the area of public health.
The Director met ENVI Chair Adina-Ioana Valean in October 2017 to raise awareness of the public health implications of: increased rates of drug-related deaths in Europe; the public health threat posed by potent synthetic opioids; the impact of hepatitis C infection on public health across Europe; and the rise of internet drug markets.
Additional topics highlighted included: challenges posed by new drugs; use of synthetic cannabinoids by homeless and prison populations; recent increases in drug purity; and the potential benefits of new treatments for hepatitis C.
Through its Strategy 2025 and Programming document 2018–20, the EMCDDA is committed to contributing to a healthier and more secure Europe. Closer links with the ENVI Committee will allow the agency — with its capacity to collect and analyse objective data on public health phenomena across Europe — to contribute to the development of European public health policy.
The ENVI Committee meeting will be web streamed: 19 February 2018 -- 16.00 to 16.45 (Brussels time)